In CD33-positive acute myeloid leukaemia (AML), leukemic blast cells are recognized by a specific anti-CD33 antibody that causes cytotoxicity due to its decoration with calicheamicins [97]. The gene discussed is CD33; the disease is acute myeloid leukemia.